ANAVEX LIFE SCIENCES CORP.
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$51.4 | -$52.9 | -$55.8 | -$51.0 | -$42.0 |
| Net income | -$46.4 | -$43.0 | -$47.5 | -$48.0 | -$37.9 |
| Cash Flow Statement | |||||
| Share repurchases | — | $11.3 | $27.9 | — | $24.1 |
Shares outstanding 92.7M · Free float 81.2%
Annual filing data through FY ended September 30, 2025; float as of September 9, 2026.